Kazia Therapeutics Limited (KZIA) Stock Price, News, Quote & History

By Yahoo! Finance | Jul 10, 2024 at 09:50 PM EST

Kazia Therapeutics Limited, an oncology-focused biotech company, is developing Paxalisib for glioblastoma and EVT801 for vascular endothelial growth factor receptor 3. Established in 1994 in Sydney, Australia, it was previously known as Novogen Limited.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.